Skip to main content
    N

    Neogen Corporation (NEOG)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $10.88
    -0.35 (-3.12%)

    Market Cap: $2.45B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Neogen Corporation (NEOG) Earnings: Report Dates and Results

    Updated Oct 6, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Neogen (NEOG) is expected to report earnings on Jan 6, 2027. In the quarter ended Aug 31, 2026, Neogen reported EPS of $0.07, above the $0.04 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    38%(15/40)
    Avg Surprise
    +23.72%
    Streak
    4 Q

    Upcoming Estimates

    Reports Jan 6, 2027 (est.)Period ending Nov 30, 2026
    EPS Consensus$0.06
    Range$0.06 - $0.07
    3 analysts
    EPS Revisions
    0
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$0.10-34.5%
    60d ago$0.09-32.2%
    30d ago$0.09-32.2%
    7d ago$0.08-20.9%
    Current$0.06
    Revenue Consensus
    $223.05M
    Range$222.20M - $223.40M
    4 analysts
    Reports Apr 7, 2027 (est.)Period ending Feb 28, 2027
    EPS Consensus$0.08
    Range$0.07 - $0.10
    3 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.07+24.9%
    60d ago$0.07+13.6%
    30d ago$0.07+13.6%
    7d ago$0.07+28.2%
    Current$0.08
    Revenue Consensus
    $214.32M
    Range$213.10M - $215.10M
    4 analysts

    Next Report

    NEOG has an expected report date of Jan 6, 2027. Analysts' consensus for the quarter ending Nov 30, 2026 is 40.0% below the $0.10 reported for the quarter ended Nov 30, 2025.

    NEOG Earnings Call

    The latest NEOG earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, NEOG beat 15, missed 14 and matched 11. Revenue for the quarter ended Aug 31, 2026 was $222.80M, up 6.5% from $209.20M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Aug 31, 2026$0.07$0.04N/A+75.00%Beat+75.0%30 up, 1 downOct 6, 2026$222.80M
    May 31, 2026$0.08$0.03N/A+166.67%Beat+60.0%31 up, 0 downJul 30, 2026$225.32M
    Feb 28, 2026$0.09$0.05$0.04 - $0.07+80.00%Beat-10.0%30 up, 2 downApr 9, 2026$211.20M
    Nov 30, 2025$0.10$0.07$0.06 - $0.07+42.86%Beat-9.1%30 up, 1 downJan 8, 2026$224.69M
    Aug 31, 2025$0.04$0.04$0.03 - $0.050.00%In line-42.9%30 up, 0 downOct 9, 2025$209.20M
    May 31, 2025$0.05-$0.03N/A+266.67%Beat-50.0%20 up, 1 downJul 29, 2025$225.48M
    Feb 28, 2025$0.10$0.12$0.11 - $0.12-16.67%Miss-16.7%20 up, 1 downApr 9, 2025$221.00M
    Nov 30, 2024$0.11$0.11$0.10 - $0.110.00%In line0.0%20 up, 1 downJan 10, 2025$231.26M
    Aug 31, 2024$0.07$0.09$0.08 - $0.09-22.22%Miss-36.4%20 up, 0 downOct 10, 2024$216.96M
    May 31, 2024$0.10$0.12$0.11 - $0.12-16.67%Miss-28.6%20 up, 0 downJul 30, 2024$236.79M
    Feb 29, 2024$0.12$0.14$0.14 - $0.14-14.29%Miss0.0%10 up, 0 downApr 9, 2024$228.81M
    Nov 30, 2023$0.11$0.14$0.14 - $0.14-21.43%Miss-26.7%10 up, 0 downJan 9, 2024$229.63M
    Aug 31, 2023$0.11$0.13$0.11 - $0.14-15.38%Miss-26.7%20 up, 0 downOct 10, 2023$216.96M
    May 31, 2023$0.14-$0.04-$0.07 - $0.00+450.00%Beat0.0%20 up, 0 downJul 27, 2023$241.81M
    Feb 28, 2023$0.12$0.15N/A-20.00%Miss-7.7%20 up, 0 downMar 30, 2023$218.25M
    Nov 30, 2022$0.15$0.14N/A+7.14%Beat+50.0%10 up, 0 downJan 5, 2023$230.03M
    Aug 31, 2022$0.15$0.15N/A0.00%In line-6.3%10 up, 0 downSep 27, 2022$132.35M
    May 31, 2022$0.14$0.12$0.08 - $0.15+16.67%Beat-6.7%20 up, 0 downJul 26, 2022$140.09M
    Feb 28, 2022$0.13$0.15$0.15 - $0.15-13.33%Miss0.0%10 up, 0 downMar 24, 2022$128.24M
    Nov 30, 2021$0.10$0.17$0.17 - $0.17-41.18%Miss-33.3%10 up, 0 downDec 21, 2021$130.52M
    Aug 31, 2021$0.16$0.16$0.15 - $0.170.00%In line+6.7%3N/ASep 21, 2021$128.31M
    May 31, 2021$0.15$0.17$0.16 - $0.17-11.76%Miss-6.3%3N/AJul 20, 2021$127.42M
    Feb 28, 2021$0.13$0.13$0.12 - $0.140.00%In line+8.3%3N/AMar 23, 2021$116.71M
    Nov 30, 2020$0.15$0.16$0.15 - $0.16-6.25%Miss-6.3%3N/ADec 22, 2020$115.00M
    Aug 31, 2020$0.15$0.14$0.14 - $0.15+7.14%Beat+7.1%4N/ASep 22, 2020$109.33M
    May 31, 2020$0.16$0.15$0.13 - $0.17+6.67%Beat+6.7%4N/AJul 21, 2020$109.07M
    Feb 29, 2020$0.12$0.14$0.13 - $0.15-14.29%Miss-7.7%5N/AMar 24, 2020$99.87M
    Nov 30, 2019$0.16$0.16$0.16 - $0.170.00%In line0.0%5N/ADec 23, 2019$107.80M
    Aug 31, 2019$0.14$0.15$0.15 - $0.16-6.67%Miss0.0%6N/ASep 24, 2019$101.42M
    May 31, 2019$0.15$0.15$0.13 - $0.160.00%In line-11.8%6N/AJul 23, 2019$109.76M
    Feb 28, 2019$0.13$0.14$0.13 - $0.14-7.14%Miss0.0%6N/AMar 26, 2019$97.70M
    Nov 30, 2018$0.16$0.15$0.15 - $0.16+6.67%Beat+23.1%7N/ADec 20, 2018$107.10M
    Aug 31, 2018$0.14$0.14$0.14 - $0.150.00%In line+16.7%7N/ASep 25, 2018$99.63M
    May 31, 2018$0.17$0.15$0.14 - $0.17+13.33%Beat+41.7%8N/AJul 17, 2018$108.12M
    Feb 28, 2018$0.13$0.11$0.10 - $0.13+18.18%Beat+30.0%8N/AMar 22, 2018$94.90M
    Nov 30, 2017$0.13$0.13$0.12 - $0.140.00%In line+18.2%8N/AJan 3, 2018$100.70M
    Aug 31, 2017$0.12$0.11N/A+9.09%Beat+20.0%7N/ASep 19, 2017$94.21M
    May 31, 2017$0.12$0.12N/A0.00%In line+20.0%6N/AJul 18, 2017$95.53M
    Feb 28, 2017$0.10$0.10N/A0.00%In line+25.0%N/AN/AMar 21, 2017$88.39M
    Nov 30, 2016$0.11$0.10N/A+10.00%Beat+22.2%N/AN/ADec 21, 2016$90.72M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended May 31, 2026 was $0.31, within 4 cents of the year before. It was $0.43 for the year ended May 31, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    May 31, 2026$0.31N/A
    May 31, 2025$0.33-25.0%
    May 31, 2024$0.44-21.4%
    May 31, 2023$0.56N/A
    May 31, 2022$0.53-8.6%
    May 31, 2021$0.58N/A
    May 31, 2020$0.58N/A
    May 31, 2019$0.58N/A
    May 31, 2018$0.55+27.9%
    May 31, 2017$0.43N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,200 words across 9 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20267,2219
    2026Q2Jun 30, 20265,9448
    2026Q1Mar 31, 20267,5579
    2025Q4Dec 31, 20255,4117
    2025Q3Sep 30, 20257,9348
    2025Q2Jun 30, 20256,8538
    2025Q1Mar 31, 20255,0827
    2024Q4Dec 31, 20244,6406

    2026Q3 Earnings Call

    Opening remarks

    Scott Gleason Head of Investor Relations Thank you for joining us this morning for the discussion of our fiscal third quarter 2026 earnings. I'll briefly cover the non-GAAP and forward-looking language before passing the call over to our CEO, Mike Nassif; and our CFO, Bryan Riggsbee. Before the market opened today, we published our third quarter results as well as a presentation with both documents available in the Investor Relations section of our website. On our call this morning, we will refer to certain non-GAAP financial measures that we believe are useful in evaluating our performance. Reconciliations of historical non-GAAP financial measures are included in our earnings release and the presentation, Slide 2 of which provides a reminder that our remarks will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act. These forward-looking statements are subject to risks that could cause actual results to be materially different from those expressed in or implied by such forward-looking statements. These risks include, among others, matters that we have described in our most recent annual report on Form 10-K and in other filings we make with the SEC. We disclaim any obligation to update these forward-looking statements. I'm now pleased to turn the call over to our CEO, Mike Nassif.

    Mike Nassif Chief Executive Officer (CEO) Good morning, everyone, and thank you for joining us. I'm happy to report that we delivered solid core growth in our Food Safety segment again this quarter, including continued growth in the United States. And our growth in the quarter was consistent with current market dynamics. This is an important milestone to achieve our goal of above-market growth. We improved our adjusted EBITDA margins to some of the highest levels in recent company history at 22.8% through cost discipline. This bodes well for our future as we look to accelerate top line growth in fiscal year 2027 and beyond and helps demonstrate the inherent financial leverage in the business. At the same time, we encountered several supplier challenges stemming from third-party manufacturers that unfortunately had a meaningful impact on our Animal Safety business. While many of these issues were outside of our direct control, they don't meet the standards we've established as an organization. So in response, we've implemented a more rigorous supplier qualification and review process to strengthen reliability going forward. Meeting our customer needs remains our highest priority, and we're addressing these challenges head on with urgency and discipline. As we look at our transformation journey, we continue to be focused on three major strategic initiatives to stabilize and strengthen our mission as the market leader in food safety. First, commercial prowess. We're strengthening our sales and marketing engine by deploying an enhanced go-to-market strategy.

    Frequently Asked Questions About NEOG

    When is Neogen's next earnings date?

    Neogen's next earnings report is expected for Jan 6, 2027.

    Did NEOG beat earnings estimates last quarter?

    Yes. Neogen reported EPS of $0.07 for the quarter ended Aug 31, 2026, above the $0.04 estimate, a 75.00% surprise.

    What EPS do analysts expect from NEOG next quarter?

    The consensus EPS estimate for Neogen for the quarter ending Nov 30, 2026 is $0.06 from 3 analysts, with estimates from $0.06 to $0.07.

    How often does NEOG beat earnings estimates?

    Neogen beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +76.82%.